sq-11725 has been researched along with Esophageal Varices in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (8.20) | 18.7374 |
1990's | 11 (18.03) | 18.2507 |
2000's | 34 (55.74) | 29.6817 |
2010's | 11 (18.03) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayes, P; Robertson, M | 1 |
Bendtsen, F; Gluud, LL; Hobolth, L; Jeyaraj, R; Morgan, MY; Zacharias, AP | 1 |
Bai, M; Fan, D; Han, G; Qi, X; Yang, M | 1 |
Advani, S; Cao, Y; El-Serag, HB; Kanwal, F; Kramer, J; Shukla, R; Tansel, A; Walder, A; Ying, J | 1 |
Chan, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL; Yu, HC | 1 |
Aracil, C; Balanzo, J; Colomo, A; Gonzalez, B; Guarner, C; Lopez-Balaguer, JM; Piqueras, M; Torras, X; Villanueva, C | 1 |
Abraldes, JG; Albillos, A; Bañares, R; Bosch, J; García-Pagán, JC; Morillas, R; Villanueva, C | 1 |
Alvarez-Urturi, C; Aracil, C; Balanzó, J; Colomo, A; Guarner, C; Hernández-Gea, V; López-Balaguer, JM; Torras, X; Villanueva, C | 1 |
Chan, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL | 1 |
Altamirano, JT; Augustin, S; Esteban, R; Genescà, J; González, A; Guardia, J; Muntaner, L | 1 |
Chen, WC; Lee, CC; Lo, GH; Wang, HM | 1 |
Abraldes, JG; Berzigotti, A; Bosch, J; Garcia-Pagan, JC; Saez, R; Tandon, P | 1 |
Talwalkar, JA | 1 |
Abu-Suboh, M; Armengol, JR; Augustin, S; Dot, J; Esteban, R; Genescà, J; González, A; Guardia, J; Pérez, M; Romero, A; Segarra, A | 1 |
Choe, WH; Kim, JH; Ko, SY; Kwon, SY; Lee, CH | 1 |
Chen, WC; Lo, GH; Wang, HM; Yu, HC | 1 |
Lock, G; Messmann, H; Wiest, R | 1 |
Bissoli, F; Borroni, G; Cazzaniga, M; de Franchis, R; Lorenzano, E; Maggi, A; Panzeri, A; Salerno, F; Visentin, S | 1 |
Barkin, JS; Maldonado, D | 1 |
Chen, MH; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL | 1 |
Abecasis, R; Ameigeiras, B; Argonz, J; Dominguez, N; Fassio, E; Garcia, D; Isla, R; Kravetz, D; Landeira, G; Romero, G; Terg, R | 1 |
Chen, MH; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Lin, CP; Lo, CC; Lo, GH | 1 |
Aracil, C; Balanzó, J; González, B; Guarner, C; Kolle, L; López-Balaguer, JM; Miñana, J; Soriano, G; Villanueva, C | 1 |
Gawrieh, S; Saeian, K | 1 |
Bhaskar, ME | 1 |
Angeli, P; Bellini, B; Bernardinello, E; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Merkel, C; Torboli, P; Zanella, P | 1 |
Mann, NS | 1 |
Brullet, E; de la Peña, J; Garcia Suárez, C; Martin-Lorente, JL; Rivero, M; Sanchez-Hernández, E; Vergara, M | 1 |
Gupta, R; Sarin, SK; Shahi, H; Wadhawan, M | 1 |
Bosch, J | 2 |
Balanzo, J; Cusso, X; Gallego, A; Gonzalez-Suarez, B; Guarner, C; Minana, J; Sainz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
Stiegmann, GV | 1 |
Argonz, J; Bosco, A; Dominguez, N; Fassio, E; Kravetz, D; Muñoz, A; Romero, G; Salgado, P; Suarez, A; Terg, R; Vulcano, C | 1 |
Laleman, W; Nevens, F | 1 |
Chan, HH; Chen, WC; Cheng, LC; Hsu, PI; Lai, KH; Lo, GH; Tsai, WL; Wang, HM | 1 |
Bernardi, M; Berzigotti, A; Bracci, E; Caraceni, P; Di Micoli, A; Domenicali, M; Felline, P; Savelli, F; Trevisani, F; Zambruni, A; Zoli, M | 1 |
Battaglia, G; Gatta, A; Merkel, C; Milani, L; Sacerdoti, D; Zuin, R | 1 |
Amodio, P; Angeli, P; Cavallarin, G; Donada, C; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sebastianelli, G; Torboli, P | 1 |
Bellon, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Bolognesi, M; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Balanzó, J; González, D; Martínez, FJ; Sáinz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
Campanati, L; Di Mauro, P; Gridelli, B; Langer, M; Peta, M; Pezzi, A; Pifferi, S; Prato, P; Proietti, D; Quarenghi, E | 1 |
Balanzó, J; Cussó, X; Guarner, C; Novella, MT; Sáinz, S; Soriano, G; Torras, X; Vilardell, F; Villanueva, C | 1 |
Chambliss, ML; Stevermer, JJ | 1 |
Amodio, P; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Mazzaro, C; Merkel, C; Sacerdoti, D; Sebastianelli, G; Torboli, P | 1 |
Chen, MH; Cheng, JS; Hsu, PI; Huang, HC; Lai, KH; Lin, CK; Lo, GH | 1 |
Assi, SA; Sanyal, A; Schubert, ML | 1 |
Bellini, B; Bighin, R; Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Herrera, JL; Zalepuga, R | 1 |
Balanzó, J; Boadas, J; Cussó, X; Gallego, A; Guarner, C; Miñana, J; Ortiz, J; Sáinz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
Novick, DM | 1 |
Blendis, L; Wong, F | 1 |
Elder, CA; Restino, MS | 1 |
Calès, P; Ideo, G; Lebrec, D; Pagliaro, L; Pascal, JP; Pasta, L; Poynard, T | 1 |
Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Bedogni, G; Beltrami, M; Bertoni, G; Castagnetti, E; Conigliaro, R; Fornaciari, G; Grazia Mortilla, M; Plancher, AC; Ricci, E | 1 |
Ohara, N; Reichen, J | 1 |
Bode, JC; Teltscher, U; Walker, S | 1 |
Benhamou, JP; Capron, JP; Chaput, JC; Geoffroy, P; Hillon, P; Lebrec, D; Poynard, T; Roulot, D; Rueff, B | 1 |
Angeli, P; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Ruol, A; Sacerdoti, D; Zuin, R | 1 |
9 review(s) available for sq-11725 and Esophageal Varices
Article | Year |
---|---|
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Topics: Adrenergic beta-Antagonists; Adult; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Primary Prevention; Propranolol; Randomized Controlled Trials as Topic; Secondary Prevention | 2018 |
Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
Topics: Combined Modality Therapy; Databases, Bibliographic; Drug Therapy, Combination; Endpoint Determination; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Isosorbide Dinitrate; Nadolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Spironolactone | 2014 |
Pharmacotherapy alone vs endoscopic variceal ligation combination for secondary prevention of oesophageal variceal bleeding: meta-analysis.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Ligation; Nadolol; Propranolol; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2012 |
Evolution of endoscopic therapy for esophageal varices.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Endoscopy, Digestive System; Esophageal and Gastric Varices; Forecasting; Gastrointestinal Hemorrhage; Humans; Ligation; Meta-Analysis as Topic; Nadolol; Prospective Studies; Randomized Controlled Trials as Topic; Sclerotherapy; Sucralfate; Treatment Outcome; Vasoconstrictor Agents | 2006 |
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents | 2006 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Beta-adrenergic antagonists for primary prevention of gastrointestinal hemorrhage in patients with cirrhosis and esophageal varices.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Propranolol | 1992 |
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter
Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol | 1991 |
Pharmacological therapy of portal hypertension.
Topics: Acute Disease; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hypertension, Portal; Nadolol; Propranolol; Somatostatin; Vasopressins | 1986 |
37 trial(s) available for sq-11725 and Esophageal Varices
Article | Year |
---|---|
Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Digestive System Surgical Procedures; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Secondary Prevention; Treatment Outcome; Vasodilator Agents | 2008 |
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Venous Pressure | 2009 |
Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Combined Modality Therapy; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Prospective Studies; Secondary Prevention; Survival Analysis; Treatment Outcome; Vasodilator Agents | 2009 |
Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Portal Pressure; Predictive Value of Tests; Proportional Hazards Models; Propranolol; Risk Assessment; ROC Curve; Time Factors; Treatment Outcome | 2009 |
A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding.
Topics: Adrenergic beta-Antagonists; Chi-Square Distribution; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Proportional Hazards Models; Recurrence; Treatment Outcome; Vasodilator Agents | 2009 |
High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Nadolol; Regression Analysis; Temperance | 2010 |
Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding.
Topics: Adrenergic beta-Antagonists; Aged; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Male; Middle Aged; Nadolol | 2010 |
Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy.
Topics: Acute Disease; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Somatostatin; Treatment Outcome | 2012 |
Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Chi-Square Distribution; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Propanolamines; Proportional Hazards Models; Secondary Prevention; Vasodilator Agents | 2012 |
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Rate; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Nadolol; Survival Rate; Treatment Outcome; Vasodilator Agents | 2002 |
Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Secondary Prevention; Treatment Failure; Vasodilator Agents | 2002 |
Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
Topics: Adrenergic beta-Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Spironolactone; Splanchnic Circulation; Treatment Outcome | 2003 |
Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal and Gastric Varices; Esophagoscopy; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Nadolol; Probability; Proportional Hazards Models; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2004 |
Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Ascites; Esophageal and Gastric Varices; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nadolol; Prognosis | 2004 |
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Disease-Free Survival; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Nadolol; Placebos | 2004 |
Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Male; Middle Aged; Nadolol; Prospective Studies; Recurrence | 2005 |
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2005 |
Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis?
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Biopsy; Disease Progression; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Follow-Up Studies; Humans; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Nadolol; Single-Blind Method; Treatment Outcome | 2005 |
Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis.
Topics: Adrenergic beta-Antagonists; Bacterial Infections; Community-Acquired Infections; Drug Therapy, Combination; Epidemiologic Methods; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Peritonitis; Sclerotherapy; Secondary Prevention; Vasodilator Agents | 2006 |
Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.
Topics: Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Sclerotherapy; Secondary Prevention | 2006 |
Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients.
Topics: Adult; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol | 2006 |
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Hepatic Veins; Humans; Liver Cirrhosis; Male; Middle Aged; Models, Biological; Nadolol; Prognosis; Risk Factors; Ventricular Function | 2008 |
Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale.
Topics: Adolescent; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Nadolol; Venous Pressure | 1995 |
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Topics: Administration, Oral; Adult; Aged; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Liver; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged; Nadolol; Pulsatile Flow; Splanchnic Circulation; Ultrasonography, Doppler, Color; Vascular Resistance; Vasodilator Agents | 1995 |
Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Topics: Adult; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Renal Circulation; Splanchnic Circulation; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1994 |
[Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging].
Topics: Adult; Aged; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Prospective Studies; Recurrence; Sclerotherapy | 1994 |
Beta-adrenergic antagonists to prevent bleeding from esophageal varices: a risk during liver transplantation?
Topics: Adult; Cardiac Output; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Monitoring, Intraoperative; Nadolol; Oxygen; Propranolol; Risk Factors | 1994 |
Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nadolol; Recurrence; Sclerotherapy; Survival Analysis; Treatment Outcome; Vasodilator Agents | 1996 |
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Randomized Controlled Trials as Topic | 2000 |
Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Male; Middle Aged; Nadolol; Postoperative Complications; Prospective Studies; Sclerotherapy; Secondary Prevention; Sucralfate; Survival Analysis; Treatment Outcome | 2000 |
Should nitrates be used with beta blockers to prevent variceal bleeding?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Vasodilator Agents | 2000 |
Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Postoperative Complications; Regression Analysis; Secondary Prevention; Survival Analysis; Vasodilator Agents | 2001 |
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter
Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol | 1991 |
Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: a randomized pilot study.
Topics: Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Pilot Projects; Random Allocation; Recurrence; Sclerotherapy | 1990 |
[Beta-receptor blockaders in the prevention of hemorrhaging of esophageal varices?].
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Drug Evaluation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Metoprolol; Nadolol; Placebos; Propranolol; Sclerosing Solutions | 1987 |
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial.
Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Nadolol; Patient Compliance | 1988 |
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial.
Topics: Adult; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nadolol; Random Allocation; Recurrence | 1987 |
16 other study(ies) available for sq-11725 and Esophageal Varices
Article | Year |
---|---|
Primary prophylaxis of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Propanolamines; Propranolol | 2018 |
Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Ascites; Cohort Studies; Comorbidity; Dose-Response Relationship, Drug; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Heart Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Nadolol; Primary Prevention; Proportional Hazards Models; Propranolol; Retrospective Studies; Risk Assessment; Risk Factors; United States; United States Department of Veterans Affairs | 2016 |
A specialized, nurse-run titration clinic: a feasible option for optimizing beta-blockade in non-clinical trial patients.
Topics: Adrenergic beta-Antagonists; Ambulatory Care Facilities; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Practice Patterns, Nurses'; Propranolol; Prospective Studies; Treatment Outcome | 2010 |
Evening administration of long-acting beta-blockers for primary prophylaxis in cirrhosis: an effective strategy.
Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Drug Administration Schedule; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Primary Prevention; Propranolol; Treatment Outcome | 2011 |
[Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding].
Topics: Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Randomized Controlled Trials as Topic; Recurrence | 2002 |
Combined therapy for secondary prophylaxis of variceal rebleeding?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Postoperative Complications; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Vasodilator Agents | 2002 |
Management of esophageal varices: an update from Digestive Disease Week and American Association for the Study of Liver Diseases 2003.
Topics: Adrenergic beta-Antagonists; Disease Progression; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Ligation; Nadolol; Recurrence | 2004 |
Management of cirrhosis and ascites.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2004 |
Nadolol versus band ligation for prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Chronotherapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Nadolol; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Diuresis; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Nadolol; Propanolamines; Renal Circulation | 1984 |
Prevention of variceal rebleeding.
Topics: Acute Disease; Adrenergic beta-Antagonists; Diuretics, Osmotic; Drug Combinations; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Sclerotherapy; Treatment Outcome | 1996 |
Beta-blocker plus nitrate for primary prophylaxis of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Nadolol; Portal System; Propranolol | 2000 |
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents | 2000 |
Prevention of recurrent variceal bleeding.
Topics: Adrenergic beta-Antagonists; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Nadolol; Secondary Prevention | 2002 |
Prevention of varices rebleeding: are drugs better after all?
Topics: Adrenergic beta-Antagonists; Diuretics, Osmotic; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide; Nadolol; Recurrence | 2002 |
Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis.
Topics: Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Male; Nadolol; Time Factors | 1991 |